A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

840

Participants

Timeline

Start Date

December 14, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL

MCV4

1 dose of MCV4 on Day 0

BIOLOGICAL

MPSV4

1 dose of MPSV4 on Day0

Trial Locations (2)

Dengfeng Center for Disease Control and Prevention, Dengfeng

Kaifeng Center for Disease Control and Prevention, Kaifeng